Recent advances in targeting the "undruggable" proteins: from drug discovery to clinical trials.
Xie X, Yu T, Li X, Zhang N, Foster LJ, Peng C, Huang W, He G. · 2023
Read Recent advances in targeting the "undruggable" proteins: from drug discovery to clinical trials. by Xie X, Yu T, Li X, Zhang N, Foster LJ, Peng C, Huang W, He G. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10480221.txt.
Introduction
Xie and co-authors reviewed in 2023 how drug hunters now chase proteins once deemed undruggable. Such proteins have shapes or jobs that defy the usual drug design playbook. Their size and smooth surfaces leave no snug pocket for a drug to grip. Yet many drive major diseases, so the prize for success is large.
Fresh tactics fill the review by Xie. Some drugs bind for good to a target, while others grip a side pocket to shut it down. Other routes break the protein, silence its gene, or block its talks with partners. RNA-based drugs and immune therapy add more angles. The team tracks which of these have reached patient trials.
Catalog record
| CREATOR | Xie X, Yu T, Li X, Zhang N, Foster LJ, Peng C, Huang W, He G. |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 371 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |